Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

53
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Nature cancer·2026
Same author

Functional and morphological alterations of light detection circuits in postmortem retina from donors with different stages of Alzheimer's-like pathology.

Communications biology·2026
Same author

X-linked hypophosphatemia and spinal cord compression: a systematic review and illustrative case.

Acta neurochirurgica·2026
Same author

[Kikuchi-Fujimoto disease : a differential diagnosis of febrile lymphadenopathy].

Revue medicale suisse·2026
Same author

Azacitidine-induced remission enables allogeneic transplantation in <i>TET2</i>/<i>BCOR</i>-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report.

Haematologica·2026
Same author

Neurons undergo IFNγ-driven persistent epigenetic shifts and synaptopathy in encephalitis.

Neuron·2025

Related Experiment Video

Updated: May 3, 2026

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

10.8K

Rheumatoid Arthritis Associated With Anti-Signal Recognition Particle Immune-Mediated Necrotizing Myopathy: A Case

Mohamed Reda Belkhribchia1, Johannes Alexander Lobrinus2, Lamyaa Semlil1

  • 1Hassan II Regional Hospital, Dakhla, Morocco.

Journal of Investigative Medicine High Impact Case Reports
|February 14, 2024
PubMed
Summary

Immune-mediated necrotizing myopathy (IMNM) associated with rheumatoid arthritis is rare. A patient with anti-SRP IMNM and RA showed significant improvement with rituximab and cyclophosphamide therapy.

Area of Science:

  • Rheumatology
  • Neurology
  • Immunology

Background:

  • Immune-mediated necrotizing myopathy (IMNM) is a rare idiopathic inflammatory myopathy.
Keywords:
anti-signal recognition particle antibodiescyclophosphamideimmune-mediated necrotizing myopathypathologyrheumatoid arthritisrheumatologyrituximab

More Related Videos

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

134.7K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

107

Related Experiment Videos

Last Updated: May 3, 2026

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

10.8K
Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

134.7K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

107
  • It presents with severe muscle weakness, necrosis, and elevated creatine kinase.
  • Anti-signal recognition particle (anti-SRP) and anti-HMGCR autoantibodies are found in many IMNM cases.